speb/financial-data huggingface dataset:
COV.V cash_flow (quarterly, 2024-09-30) — Common Stock Payments: 0.00
COV.V income_statement (annual, 2024-09-30) — Cost Of Revenue: 12235807.00
COV.V balance_sheet (annual, 2024-09-30) — Current Assets: 29038951.00
COV.V balance_sheet (annual, 2024-09-30) — Current Capital Lease Obligation: 600485.00
COV.V balance_sheet (annual, 2024-09-30) — Current Debt And Capital Lease Obligation: 600485.00
COV.V balance_sheet (annual, 2024-09-30) — Current Deferred Liabilities: 72082.00
COV.V balance_sheet (annual, 2024-09-30) — Current Deferred Revenue: 72082.00
COV.V balance_sheet (annual, 2024-09-30) — Current Liabilities: 3996357.00
COV.V cash_flow (annual, 2024-09-30) — Depreciation: 684091.00
COV.V cash_flow (annual, 2024-09-30) — Depreciation Amortization Depletion: 986458.00
COV.V cash_flow (annual, 2024-09-30) — Depreciation And Amortization: 986458.00
COV.V income_statement (annual, 2024-09-30) — Diluted Average Shares: 24270836.00
COV.V income_statement (annual, 2024-09-30) — Diluted EPS: 0.11
COV.V income_statement (annual, 2024-09-30) — Diluted NI Availto Com Stockholders: 2669792.00
COV.V income_statement (annual, 2024-09-30) — EBIT: 2151033.00
COV.V income_statement (annual, 2024-09-30) — EBITDA: 3137491.00
COV.V cash_flow (annual, 2024-09-30) — Effect Of Exchange Rate Changes: -211281.00
COV.V cash_flow (annual, 2024-09-30) — End Cash Position: 16746781.00
COV.V cash_flow (annual, 2024-09-30) — Financing Cash Flow: 4972062.00
COV.V balance_sheet (annual, 2024-09-30) — Finished Goods: 6372772.00
COV.V balance_sheet (annual, 2024-09-30) — Foreign Currency Translation Adjustments: 3130413.00
COV.V cash_flow (annual, 2024-09-30) — Free Cash Flow: 3056150.00
COV.V cash_flow (annual, 2024-09-30) — Gain Loss On Investment Securities: -610008.00
COV.V cash_flow (annual, 2024-09-30) — Gain Loss On Sale Of PPE: 80443.00
COV.V cash_flow (quarterly, 2024-09-30) — Gain Loss On Sale Of PPE: -4578.00
COV.V balance_sheet (annual, 2024-09-30) — Gains Losses Not Affecting Retained Earnings: 3130413.00
COV.V income_statement (annual, 2024-09-30) — General And Administrative Expense: 7781398.00
COV.V balance_sheet (annual, 2024-09-30) — Goodwill And Other Intangible Assets: 1439714.00
COV.V balance_sheet (annual, 2024-09-30) — Gross PPE: 3719116.00
COV.V income_statement (annual, 2024-09-30) — Gross Profit: 18932725.00
COV.V balance_sheet (annual, 2024-09-30) — Inventories Adjustments Allowances: -2197523.00
COV.V balance_sheet (annual, 2024-09-30) — Inventory: 7696084.00
COV.V balance_sheet (annual, 2024-09-30) — Invested Capital: 27504608.00
COV.V cash_flow (annual, 2024-09-30) — Investing Cash Flow: -281635.00
COV.V cash_flow (annual, 2024-09-30) — Issuance Of Debt: 214005.00
COV.V balance_sheet (annual, 2024-09-30) — Leases: 382755.00
COV.V balance_sheet (annual, 2024-09-30) — Long Term Capital Lease Obligation: 301186.00
COV.V balance_sheet (annual, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 301186.00
COV.V cash_flow (annual, 2024-09-30) — Long Term Debt Issuance: 214005.00
COV.V cash_flow (annual, 2024-09-30) — Long Term Debt Payments: -698943.00
COV.V balance_sheet (annual, 2024-09-30) — Machinery Furniture Equipment: 485114.00
COV.V cash_flow (annual, 2024-09-30) — Net Common Stock Issuance: 0.00
COV.V cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: 0.00
COV.V income_statement (annual, 2024-09-30) — Net Income: 2669792.00
COV.V income_statement (annual, 2024-09-30) — Net Income Common Stockholders: 2669792.00
COV.V income_statement (annual, 2024-09-30) — Net Income Continuous Operations: 2669792.00
COV.V income_statement (annual, 2024-09-30) — Net Income From Continuing And Discontinued Operation: 2669792.00
COV.V income_statement (annual, 2024-09-30) — Net Income From Continuing Operation Net Minority Interest: 2669792.00
COV.V cash_flow (annual, 2024-09-30) — Net Income From Continuing Operations: 2669792.00
COV.V income_statement (annual, 2024-09-30) — Net Income Including Noncontrolling Interests: 2669792.00
COV.V cash_flow (annual, 2024-09-30) — Net Intangibles Purchase And Sale: -126190.00
COV.V income_statement (annual, 2024-09-30) — Net Interest Income: -91249.00
COV.V cash_flow (annual, 2024-09-30) — Net Issuance Payments Of Debt: -484938.00
COV.V cash_flow (annual, 2024-09-30) — Net Long Term Debt Issuance: -484938.00
COV.V income_statement (annual, 2024-09-30) — Net Non Operating Interest Income Expense: -91249.00
COV.V cash_flow (annual, 2024-09-30) — Net Other Investing Changes: 135200.00
COV.V cash_flow (quarterly, 2024-09-30) — Net Other Investing Changes: 136870.00
COV.V balance_sheet (annual, 2024-09-30) — Net PPE: 1179181.00
COV.V cash_flow (annual, 2024-09-30) — Net PPE Purchase And Sale: -290645.00
COV.V balance_sheet (annual, 2024-09-30) — Net Tangible Assets: 26064894.00
COV.V balance_sheet (annual, 2024-09-30) — Non Current Accounts Receivable: 148728.00
COV.V balance_sheet (quarterly, 2024-09-30) — Non Current Accounts Receivable: 148728.00
COV.V income_statement (annual, 2024-09-30) — Normalized EBITDA: 3137491.00
COV.V income_statement (annual, 2024-09-30) — Normalized Income: 2669792.00
COV.V cash_flow (annual, 2024-09-30) — Operating Cash Flow: 3472985.00
COV.V cash_flow (annual, 2024-09-30) — Operating Gains Losses: -529565.00
COV.V income_statement (annual, 2024-09-30) — Operating Income: 2151033.00
COV.V income_statement (annual, 2024-09-30) — Operating Revenue: 31168532.00
COV.V balance_sheet (annual, 2024-09-30) — Ordinary Shares Number: 27398077.00
COV.V income_statement (annual, 2024-09-30) — Other Gand A: 7781398.00
COV.V income_statement (annual, 2024-09-30) — Other Income Expense: 610008.00
COV.V income_statement (quarterly, 2024-09-30) — Other Income Expense: 0.00
COV.V balance_sheet (annual, 2024-09-30) — Other Intangible Assets: 1439714.00
COV.V cash_flow (annual, 2024-09-30) — Other Non Cash Items: 56246.00
COV.V income_statement (annual, 2024-09-30) — Other Non Operating Income Expenses: 610008.00
COV.V income_statement (quarterly, 2024-09-30) — Other Non Operating Income Expenses: 0.00
COV.V income_statement (annual, 2024-09-30) — Other Operating Expenses: 1973752.00
COV.V balance_sheet (annual, 2024-09-30) — Other Properties: 2682794.00
COV.V balance_sheet (annual, 2024-09-30) — Other Receivables: 264728.00
COV.V balance_sheet (quarterly, 2024-09-30) — Other Receivables: 264728.00
COV.V balance_sheet (annual, 2024-09-30) — Payables And Accrued Expenses: 3323790.00
COV.V balance_sheet (annual, 2024-09-30) — Prepaid Assets: 686106.00
COV.V income_statement (annual, 2024-09-30) — Pretax Income: 2669792.00
COV.V cash_flow (annual, 2024-09-30) — Proceeds From Stock Option Exercised: 5457000.00
COV.V balance_sheet (annual, 2024-09-30) — Properties: 0.00
COV.V cash_flow (annual, 2024-09-30) — Purchase Of Intangibles: -126190.00
COV.V cash_flow (annual, 2024-09-30) — Purchase Of PPE: -290645.00
COV.V balance_sheet (annual, 2024-09-30) — Raw Materials: 3520835.00
COV.V balance_sheet (annual, 2024-09-30) — Receivables: 3909980.00
COV.V income_statement (annual, 2024-09-30) — Reconciled Cost Of Revenue: 12235807.00
COV.V income_statement (annual, 2024-09-30) — Reconciled Depreciation: 986458.00
COV.V cash_flow (annual, 2024-09-30) — Repayment Of Debt: -698943.00
COV.V cash_flow (annual, 2024-09-30) — Repurchase Of Capital Stock: 0.00
COV.V cash_flow (quarterly, 2024-09-30) — Repurchase Of Capital Stock: 0.00
COV.V income_statement (annual, 2024-09-30) — Research And Development: 1594079.00
COV.V balance_sheet (annual, 2024-09-30) — Retained Earnings: -35696491.00
COV.V income_statement (annual, 2024-09-30) — Selling And Marketing Expense: 5432463.00
COV.V income_statement (annual, 2024-09-30) — Selling General And Administration: 13213861.00
COV.V balance_sheet (annual, 2024-09-30) — Share Issued: 27398077.00
COV.V cash_flow (annual, 2024-09-30) — Stock Based Compensation: 405981.00
COV.V balance_sheet (annual, 2024-09-30) — Stockholders Equity: 27504608.00
COV.V balance_sheet (annual, 2024-09-30) — Tangible Book Value: 26064894.00
COV.V income_statement (annual, 2024-09-30) — Tax Effect Of Unusual Items: 0.00
COV.V income_statement (annual, 2024-09-30) — Tax Rate For Calcs: 0.15
COV.V balance_sheet (annual, 2024-09-30) — Total Assets: 31806574.00
COV.V balance_sheet (annual, 2024-09-30) — Total Capitalization: 27504608.00
COV.V balance_sheet (annual, 2024-09-30) — Total Debt: 901671.00
COV.V balance_sheet (annual, 2024-09-30) — Total Equity Gross Minority Interest: 27504608.00
COV.V income_statement (annual, 2024-09-30) — Total Expenses: 29017499.00
COV.V balance_sheet (annual, 2024-09-30) — Total Liabilities Net Minority Interest: 4301966.00
COV.V balance_sheet (annual, 2024-09-30) — Total Non Current Assets: 2767623.00
COV.V balance_sheet (annual, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 305609.00
COV.V income_statement (annual, 2024-09-30) — Total Other Finance Cost: 91249.00
COV.V income_statement (quarterly, 2024-09-30) — Total Other Finance Cost: 51509.00
COV.V balance_sheet (annual, 2024-09-30) — Tradeand Other Payables Non Current: 4423.00
COV.V balance_sheet (quarterly, 2024-09-30) — Tradeand Other Payables Non Current: 4423.00
COV.V balance_sheet (annual, 2024-09-30) — Working Capital: 25042594.00
COV.V cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 0.00
COV.V income_statement (quarterly, 2024-12-31) — Basic Average Shares: 27398077.00
COV.V income_statement (quarterly, 2024-12-31) — Basic EPS: 0.04
COV.V cash_flow (quarterly, 2024-12-31) — Cash Dividends Paid: 0.00
COV.V cash_flow (quarterly, 2024-12-31) — Common Stock Dividend Paid: 0.00
COV.V income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 28043419.00
COV.V income_statement (quarterly, 2024-12-31) — Diluted EPS: 0.04
COV.V income_statement (quarterly, 2024-12-31) — Interest Expense: 149690.00
COV.V income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 149690.00
COV.V income_statement (quarterly, 2024-12-31) — Interest Income: 41068.00
COV.V income_statement (quarterly, 2024-12-31) — Interest Income Non Operating: 41068.00
COV.V balance_sheet (quarterly, 2024-12-31) — Non Current Accounts Receivable: 50284.00
COV.V income_statement (quarterly, 2024-12-31) — Other Income Expense: -149690.00
COV.V income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: -149690.00
COV.V balance_sheet (quarterly, 2024-12-31) — Other Receivables: 170503.00
COV.V balance_sheet (quarterly, 2024-12-31) — Tradeand Other Payables Non Current: 0.00
COV.V income_statement (quarterly, 2025-03-31) — +Operating Expense: 3857686.00
COV.V income_statement (quarterly, 2025-03-31) — +Total Revenue: 7585968.00
COV.V balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 4872199.00
COV.V balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -2871997.00
COV.V balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 8453406.00
COV.V cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 99891.00
COV.V cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 99891.00
COV.V cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 0.00
COV.V income_statement (quarterly, 2025-03-31) — Basic Average Shares: 27398077.00
COV.V income_statement (quarterly, 2025-03-31) — Basic EPS: 0.02
COV.V cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 17497607.00
COV.V balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 57789.00
COV.V cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -32568.00
COV.V balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 609464.00
COV.V balance_sheet (quarterly, 2025-03-31) — Capital Stock: 51817143.00
COV.V balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 18030564.00
COV.V balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 18030564.00
COV.V cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: 0.00
COV.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -81642.00
COV.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -32568.00
COV.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 675095.00
COV.V cash_flow (quarterly, 2025-03-31) — Change In Inventory: -364962.00
COV.V cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 61779.00
COV.V cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -57314.00
COV.V cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -182438.00
COV.V cash_flow (quarterly, 2025-03-31) — Change In Receivables: 481185.00
COV.V cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -61750.00
COV.V cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 481185.00
COV.V cash_flow (quarterly, 2025-03-31) — Changes In Cash: 560885.00
COV.V balance_sheet (quarterly, 2025-03-31) — Common Stock: 51817143.00
COV.V cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: 0.00
COV.V balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 31149955.00
COV.V income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 3446462.00
COV.V balance_sheet (quarterly, 2025-03-31) — Current Assets: 32612248.00
COV.V balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 499115.00
COV.V balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 499115.00
COV.V balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 61798.00
COV.V balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 61798.00
COV.V balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 3886323.00
COV.V cash_flow (quarterly, 2025-03-31) — Depreciation: 133730.00
COV.V cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 233621.00
COV.V income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 165072.00
COV.V cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 233621.00
COV.V income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 165072.00
COV.V income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 27889506.00
COV.V income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.02
COV.V income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 429139.00
COV.V income_statement (quarterly, 2025-03-31) — EBIT: 281820.00
COV.V income_statement (quarterly, 2025-03-31) — EBITDA: 515441.00
COV.V cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -27928.00
COV.V cash_flow (quarterly, 2025-03-31) — End Cash Position: 18030564.00
COV.V cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -81642.00
COV.V balance_sheet (quarterly, 2025-03-31) — Finished Goods: 6413740.00
COV.V balance_sheet (quarterly, 2025-03-31) — Foreign Currency Translation Adjustments: 4940712.00
COV.V cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 642527.00
COV.V cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 0.00
COV.V balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 4940712.00
COV.V income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 1693295.00
COV.V balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 1430515.00
COV.V balance_sheet (quarterly, 2025-03-31) — Gross PPE: 3958000.00
COV.V income_statement (quarterly, 2025-03-31) — Gross Profit: 4139506.00
COV.V balance_sheet (quarterly, 2025-03-31) — Inventories Adjustments Allowances: -1723955.00
COV.V balance_sheet (quarterly, 2025-03-31) — Inventory: 8930379.00
COV.V balance_sheet (quarterly, 2025-03-31) — Invested Capital: 31149955.00
COV.V cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -32568.00
COV.V cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 56208.00
COV.V balance_sheet (quarterly, 2025-03-31) — Leases: 407621.00
COV.V balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 110349.00
COV.V balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 110349.00
COV.V cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 56208.00
COV.V cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -181650.00
COV.V balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 524654.00
COV.V income_statement (quarterly, 2025-03-31) — Net Income: 429139.00
COV.V income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 429139.00
COV.V income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 429139.00
COV.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 429139.00
COV.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 429139.00
COV.V cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 429139.00
COV.V income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 429139.00
COV.V cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: -11996.00
COV.V income_statement (quarterly, 2025-03-31) — Net Interest Income: 147319.00
COV.V cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -125442.00
COV.V cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -125442.00
COV.V income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 147319.00
COV.V balance_sheet (quarterly, 2025-03-31) — Net PPE: 1086003.00
COV.V cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -20572.00
COV.V balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 29719440.00
COV.V balance_sheet (quarterly, 2025-03-31) — Non Current Accounts Receivable: 17861.00
COV.V income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 515441.00
COV.V income_statement (quarterly, 2025-03-31) — Normalized Income: 429139.00
COV.V cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 675095.00
COV.V cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 0.00
COV.V income_statement (quarterly, 2025-03-31) — Operating Income: 281820.00
COV.V income_statement (quarterly, 2025-03-31) — Operating Revenue: 7585968.00
COV.V balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 27418077.00
COV.V income_statement (quarterly, 2025-03-31) — Other Gand A: 1693295.00
COV.V balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 1430515.00
COV.V cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 8545.00
COV.V income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 428698.00
COV.V balance_sheet (quarterly, 2025-03-31) — Other Properties: 2967936.00
COV.V balance_sheet (quarterly, 2025-03-31) — Other Receivables: 145606.00
COV.V balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 3325410.00
COV.V balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 633500.00
COV.V income_statement (quarterly, 2025-03-31) — Pretax Income: 429139.00
COV.V balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
COV.V cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: -11996.00
COV.V cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -20572.00
COV.V balance_sheet (quarterly, 2025-03-31) — Raw Materials: 4240594.00
COV.V balance_sheet (quarterly, 2025-03-31) — Receivables: 5017805.00
COV.V income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 3377913.00
COV.V income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 233621.00
COV.V cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -181650.00
COV.V income_statement (quarterly, 2025-03-31) — Research And Development: 320459.00
COV.V balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -34061306.00
COV.V income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 1250162.00
COV.V income_statement (quarterly, 2025-03-31) — Selling General And Administration: 2943457.00
COV.V balance_sheet (quarterly, 2025-03-31) — Share Issued: 27418077.00
COV.V income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
COV.V cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 65540.00
COV.V balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 31149955.00
COV.V balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 29719440.00
COV.V income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
COV.V income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.15
COV.V balance_sheet (quarterly, 2025-03-31) — Total Assets: 35146627.00
COV.V balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 31149955.00
COV.V balance_sheet (quarterly, 2025-03-31) — Total Debt: 609464.00
COV.V balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 31149955.00
COV.V income_statement (quarterly, 2025-03-31) — Total Expenses: 7304148.00
COV.V balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 3996672.00
COV.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 2534379.00
COV.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 110349.00
COV.V income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: -147319.00
COV.V income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
COV.V income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
COV.V balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 0.00
COV.V balance_sheet (quarterly, 2025-03-31) — Working Capital: 28725925.00
COV.V income_statement (quarterly, 2025-06-30) — +Operating Expense: 3971157.00
COV.V income_statement (quarterly, 2025-06-30) — +Total Revenue: 8372427.00
COV.V balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 4595603.00
COV.V balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -2817219.00
COV.V balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 8507784.00
COV.V cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 59471.00
COV.V cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 59471.00
COV.V cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 0.00
COV.V income_statement (quarterly, 2025-06-30) — Basic Average Shares: 27418077.00
COV.V income_statement (quarterly, 2025-06-30) — Basic EPS: 0.00
COV.V cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 18030564.00
COV.V balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 869251.00
COV.V cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -442120.00
COV.V balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 1277685.00
COV.V balance_sheet (quarterly, 2025-06-30) — Capital Stock: 51817143.00
COV.V balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 18090778.00
COV.V balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 18090778.00
COV.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -149622.00
COV.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -442120.00
COV.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 2156791.00
COV.V cash_flow (quarterly, 2025-06-30) — Change In Inventory: 873839.00
COV.V cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 22478.00
COV.V cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 873097.00
COV.V cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -234947.00
COV.V cash_flow (quarterly, 2025-06-30) — Change In Receivables: 276557.00
COV.V cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 1811024.00
COV.V cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 276557.00
COV.V cash_flow (quarterly, 2025-06-30) — Changes In Cash: 1565049.00
COV.V balance_sheet (quarterly, 2025-06-30) — Common Stock: 51817143.00
COV.V balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 29677945.00
COV.V income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 4479932.00
COV.V balance_sheet (quarterly, 2025-06-30) — Current Assets: 31731618.00
COV.V balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 545495.00
COV.V balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 545495.00
COV.V balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 84241.00
COV.V balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 84241.00
COV.V balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 4826825.00
COV.V cash_flow (quarterly, 2025-06-30) — Depreciation: 156582.00
COV.V cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 216053.00
COV.V income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 122894.00
COV.V cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 216053.00
COV.V income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 122894.00
COV.V income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 27924006.00
COV.V income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.00
COV.V income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 64567.00
COV.V income_statement (quarterly, 2025-06-30) — EBIT: -78662.00
COV.V income_statement (quarterly, 2025-06-30) — EBITDA: 137391.00
COV.V cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -1504835.00
COV.V cash_flow (quarterly, 2025-06-30) — End Cash Position: 18090778.00
COV.V cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -149622.00
COV.V balance_sheet (quarterly, 2025-06-30) — Finished Goods: 4398649.00
COV.V balance_sheet (quarterly, 2025-06-30) — Foreign Currency Translation Adjustments: 3349757.00
COV.V cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 1714671.00
COV.V cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 0.00
COV.V balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 3349757.00
COV.V income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 1922369.00
COV.V balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 1344699.00
COV.V balance_sheet (quarterly, 2025-06-30) — Gross PPE: 4977862.00
COV.V income_statement (quarterly, 2025-06-30) — Gross Profit: 3892495.00
COV.V balance_sheet (quarterly, 2025-06-30) — Inventories Adjustments Allowances: -582159.00
COV.V balance_sheet (quarterly, 2025-06-30) — Inventory: 8055970.00
COV.V balance_sheet (quarterly, 2025-06-30) — Invested Capital: 29677945.00
COV.V cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -442120.00
COV.V cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 29679.00
COV.V balance_sheet (quarterly, 2025-06-30) — Leases: 386838.00
COV.V balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 732190.00
COV.V balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 732190.00
COV.V cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 29679.00
COV.V cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -179301.00
COV.V balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 499841.00
COV.V income_statement (quarterly, 2025-06-30) — Net Income: 64567.00
COV.V income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 64567.00
COV.V income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 64567.00
COV.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 64567.00
COV.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 64567.00
COV.V cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 64567.00
COV.V income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 64567.00
COV.V cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: -41461.00
COV.V income_statement (quarterly, 2025-06-30) — Net Interest Income: 143229.00
COV.V cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -149622.00
COV.V cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -149622.00
COV.V income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 143229.00
COV.V balance_sheet (quarterly, 2025-06-30) — Net PPE: 2160643.00
COV.V cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -400659.00
COV.V balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 28333246.00
COV.V income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 137391.00
COV.V income_statement (quarterly, 2025-06-30) — Normalized Income: 64567.00
COV.V cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 2156791.00
COV.V cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 0.00
COV.V income_statement (quarterly, 2025-06-30) — Operating Income: -78662.00
COV.V income_statement (quarterly, 2025-06-30) — Operating Revenue: 8372427.00
COV.V balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 27418077.00
COV.V income_statement (quarterly, 2025-06-30) — Other Gand A: 1922369.00
COV.V balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 1344699.00
COV.V cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 10769.00
COV.V income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 493489.00
COV.V balance_sheet (quarterly, 2025-06-30) — Other Properties: 3221932.00
COV.V balance_sheet (quarterly, 2025-06-30) — Other Receivables: 120456.00
COV.V balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 4197089.00
COV.V balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 868811.00
COV.V income_statement (quarterly, 2025-06-30) — Pretax Income: 64567.00
COV.V cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
COV.V balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
COV.V cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: -41461.00
COV.V cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -400659.00
COV.V balance_sheet (quarterly, 2025-06-30) — Raw Materials: 4239480.00
COV.V balance_sheet (quarterly, 2025-06-30) — Receivables: 4716059.00
COV.V income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 4386773.00
COV.V income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 216053.00
COV.V cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -179301.00
COV.V income_statement (quarterly, 2025-06-30) — Research And Development: 311340.00
COV.V balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -33996739.00
COV.V income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 1121065.00
COV.V income_statement (quarterly, 2025-06-30) — Selling General And Administration: 3043434.00
COV.V balance_sheet (quarterly, 2025-06-30) — Share Issued: 27418077.00
COV.V cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 54378.00
COV.V balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 29677945.00
COV.V balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 28333246.00
COV.V income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
COV.V income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.15
COV.V balance_sheet (quarterly, 2025-06-30) — Total Assets: 35236960.00
COV.V balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 29677945.00
COV.V balance_sheet (quarterly, 2025-06-30) — Total Debt: 1277685.00
COV.V balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 29677945.00
COV.V income_statement (quarterly, 2025-06-30) — Total Expenses: 8451089.00
COV.V balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 5559015.00
COV.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 3505342.00
COV.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 732190.00
COV.V income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: -143229.00
COV.V balance_sheet (quarterly, 2025-06-30) — Tradeand Other Payables Non Current: 0.00
COV.V balance_sheet (quarterly, 2025-06-30) — Working Capital: 26904793.00
COV.V income_statement (annual, 2025-09-30) — +Operating Expense: 15708192.00
COV.V income_statement (quarterly, 2025-09-30) — +Operating Expense: 4199551.00
COV.V income_statement (annual, 2025-09-30) — +Total Revenue: 32816347.00
COV.V income_statement (quarterly, 2025-09-30) — +Total Revenue: 8691972.00
COV.V balance_sheet (annual, 2025-09-30) — Accounts Receivable: 5840217.00
COV.V balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 5840217.00
COV.V balance_sheet (annual, 2025-09-30) — Accumulated Depreciation: -2858053.00
COV.V balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -2858053.00
COV.V balance_sheet (annual, 2025-09-30) — Additional Paid In Capital: 8571418.00
COV.V balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 8571418.00
COV.V cash_flow (annual, 2025-09-30) — Amortization Cash Flow: 338467.00
COV.V cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 83967.00
COV.V cash_flow (annual, 2025-09-30) — Amortization Of Intangibles: 338467.00
COV.V cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 83967.00
COV.V cash_flow (annual, 2025-09-30) — Asset Impairment Charge: 0.00
COV.V cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 0.00
COV.V income_statement (annual, 2025-09-30) — Basic Average Shares: 27411099.00
COV.V income_statement (annual, 2025-09-30) — Basic EPS: 0.08
COV.V cash_flow (annual, 2025-09-30) — Beginning Cash Position: 16746781.00
COV.V cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 18090778.00
COV.V balance_sheet (annual, 2025-09-30) — Buildings And Improvements: 1886981.00
COV.V balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 1886981.00
COV.V cash_flow (annual, 2025-09-30) — Capital Expenditure: -847024.00
COV.V cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -180214.00
COV.V balance_sheet (annual, 2025-09-30) — Capital Lease Obligations: 2253740.00
COV.V balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 2253740.00
COV.V balance_sheet (annual, 2025-09-30) — Capital Stock: 51817143.00
COV.V balance_sheet (quarterly, 2025-09-30) — Capital Stock: 51817143.00
COV.V balance_sheet (annual, 2025-09-30) — Cash And Cash Equivalents: 17367288.00
COV.V balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 17367288.00
COV.V balance_sheet (annual, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 17367288.00
COV.V balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 17367288.00
COV.V cash_flow (annual, 2025-09-30) — Cash Flow From Continuing Financing Activities: -529346.00
COV.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -182037.00
COV.V cash_flow (annual, 2025-09-30) — Cash Flow From Continuing Investing Activities: -847024.00
COV.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -180214.00
COV.V cash_flow (annual, 2025-09-30) — Cash Flow From Continuing Operating Activities: 2289206.00
COV.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -667211.00
COV.V cash_flow (annual, 2025-09-30) — Change In Inventory: 819019.00
COV.V cash_flow (quarterly, 2025-09-30) — Change In Inventory: 800937.00
COV.V cash_flow (annual, 2025-09-30) — Change In Other Working Capital: -69383.00
COV.V cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -83374.00
COV.V cash_flow (annual, 2025-09-30) — Change In Payables And Accrued Expense: 39480.00
COV.V cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -987446.00
COV.V cash_flow (annual, 2025-09-30) — Change In Prepaid Assets: -107046.00
COV.V cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 48334.00
COV.V cash_flow (annual, 2025-09-30) — Change In Receivables: -1893361.00
COV.V cash_flow (quarterly, 2025-09-30) — Change In Receivables: -1150423.00
COV.V cash_flow (annual, 2025-09-30) — Change In Working Capital: -1211291.00
COV.V cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -1371972.00
COV.V cash_flow (annual, 2025-09-30) — Changes In Account Receivables: -1893361.00
COV.V cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -1150423.00
COV.V cash_flow (annual, 2025-09-30) — Changes In Cash: 912836.00
COV.V cash_flow (quarterly, 2025-09-30) — Changes In Cash: -1029462.00
COV.V balance_sheet (annual, 2025-09-30) — Common Stock: 51817143.00
COV.V balance_sheet (quarterly, 2025-09-30) — Common Stock: 51817143.00
COV.V balance_sheet (annual, 2025-09-30) — Common Stock Equity: 30726909.00
COV.V balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 30726909.00
COV.V income_statement (annual, 2025-09-30) — Cost Of Revenue: 15344483.00
COV.V income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 4246575.00
COV.V balance_sheet (annual, 2025-09-30) — Current Assets: 31530850.00
COV.V balance_sheet (quarterly, 2025-09-30) — Current Assets: 31530850.00
COV.V balance_sheet (annual, 2025-09-30) — Current Capital Lease Obligation: 627256.00
COV.V balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 627256.00
COV.V balance_sheet (annual, 2025-09-30) — Current Debt And Capital Lease Obligation: 627256.00
COV.V balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 627256.00
COV.V balance_sheet (annual, 2025-09-30) — Current Deferred Liabilities: 0.00
COV.V balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 0.00
COV.V balance_sheet (annual, 2025-09-30) — Current Deferred Revenue: 0.00
COV.V balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 0.00
COV.V balance_sheet (annual, 2025-09-30) — Current Liabilities: 3770194.00
COV.V balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 3770194.00
COV.V cash_flow (annual, 2025-09-30) — Depreciation: 616476.00
COV.V cash_flow (quarterly, 2025-09-30) — Depreciation: 164177.00
COV.V cash_flow (annual, 2025-09-30) — Depreciation Amortization Depletion: 954943.00
COV.V cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 248144.00
COV.V cash_flow (annual, 2025-09-30) — Depreciation And Amortization: 954943.00
COV.V cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 248144.00
COV.V income_statement (annual, 2025-09-30) — Diluted Average Shares: 27899185.00
COV.V income_statement (annual, 2025-09-30) — Diluted EPS: 0.07
COV.V income_statement (annual, 2025-09-30) — Diluted NI Availto Com Stockholders: 2058089.00
COV.V income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 358337.00
COV.V income_statement (annual, 2025-09-30) — EBIT: 1763672.00
COV.V income_statement (quarterly, 2025-09-30) — EBIT: 245846.00
COV.V income_statement (annual, 2025-09-30) — EBITDA: 2718615.00
COV.V income_statement (quarterly, 2025-09-30) — EBITDA: 493990.00
COV.V cash_flow (annual, 2025-09-30) — Effect Of Exchange Rate Changes: -292329.00
COV.V cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 305972.00
COV.V cash_flow (annual, 2025-09-30) — End Cash Position: 17367288.00
COV.V cash_flow (quarterly, 2025-09-30) — End Cash Position: 17367288.00
COV.V cash_flow (annual, 2025-09-30) — Financing Cash Flow: -529346.00
COV.V cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -182037.00
COV.V balance_sheet (annual, 2025-09-30) — Finished Goods: 3750901.00
COV.V balance_sheet (quarterly, 2025-09-30) — Finished Goods: 3750901.00
COV.V balance_sheet (annual, 2025-09-30) — Foreign Currency Translation Adjustments: 3976750.00
COV.V balance_sheet (quarterly, 2025-09-30) — Foreign Currency Translation Adjustments: 3976750.00
COV.V cash_flow (annual, 2025-09-30) — Free Cash Flow: 1442182.00
COV.V cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -847425.00
COV.V cash_flow (annual, 2025-09-30) — Gain Loss On Investment Securities: 149690.00
COV.V cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 0.00
COV.V cash_flow (annual, 2025-09-30) — Gain Loss On Sale Of PPE: 1145.00
COV.V cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: 1145.00
COV.V balance_sheet (annual, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 3976750.00
COV.V balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 3976750.00
COV.V income_statement (annual, 2025-09-30) — General And Administrative Expense: 7668896.00
COV.V income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 2469783.00
COV.V balance_sheet (annual, 2025-09-30) — Goodwill And Other Intangible Assets: 1350674.00
COV.V balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 1350674.00
COV.V balance_sheet (annual, 2025-09-30) — Gross PPE: 6100116.00
COV.V balance_sheet (quarterly, 2025-09-30) — Gross PPE: 6100116.00
COV.V income_statement (annual, 2025-09-30) — Gross Profit: 17471864.00
COV.V income_statement (quarterly, 2025-09-30) — Gross Profit: 4445397.00
COV.V balance_sheet (annual, 2025-09-30) — Inventories Adjustments Allowances: -415508.00
COV.V balance_sheet (quarterly, 2025-09-30) — Inventories Adjustments Allowances: -415508.00
COV.V balance_sheet (annual, 2025-09-30) — Inventory: 7400787.00
COV.V balance_sheet (quarterly, 2025-09-30) — Inventory: 7400787.00
COV.V balance_sheet (annual, 2025-09-30) — Invested Capital: 30726909.00
COV.V balance_sheet (quarterly, 2025-09-30) — Invested Capital: 30726909.00
COV.V cash_flow (annual, 2025-09-30) — Investing Cash Flow: -847024.00
COV.V cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -180214.00
COV.V cash_flow (annual, 2025-09-30) — Issuance Of Debt: 184889.00
COV.V cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 33302.00
COV.V balance_sheet (annual, 2025-09-30) — Leases: 377830.00
COV.V balance_sheet (quarterly, 2025-09-30) — Leases: 377830.00
COV.V balance_sheet (annual, 2025-09-30) — Long Term Capital Lease Obligation: 1626484.00
COV.V balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 1626484.00
COV.V balance_sheet (annual, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1626484.00
COV.V balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1626484.00
COV.V cash_flow (annual, 2025-09-30) — Long Term Debt Issuance: 184889.00
COV.V cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 33302.00
COV.V cash_flow (annual, 2025-09-30) — Long Term Debt Payments: -758035.00
COV.V cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -215339.00
COV.V balance_sheet (annual, 2025-09-30) — Machinery Furniture Equipment: 508785.00
COV.V balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 508785.00
COV.V income_statement (annual, 2025-09-30) — Net Income: 2058089.00
COV.V income_statement (quarterly, 2025-09-30) — Net Income: 358337.00
COV.V income_statement (annual, 2025-09-30) — Net Income Common Stockholders: 2058089.00
COV.V income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 358337.00
COV.V income_statement (annual, 2025-09-30) — Net Income Continuous Operations: 2058089.00
COV.V income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 358337.00
COV.V income_statement (annual, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 2058089.00
COV.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 358337.00
COV.V income_statement (annual, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 2058089.00
COV.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 358337.00
COV.V cash_flow (annual, 2025-09-30) — Net Income From Continuing Operations: 2058089.00
COV.V cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 358337.00
COV.V income_statement (annual, 2025-09-30) — Net Income Including Noncontrolling Interests: 2058089.00
COV.V income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 358337.00
COV.V cash_flow (annual, 2025-09-30) — Net Intangibles Purchase And Sale: -202846.00
COV.V cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: -66214.00
COV.V income_statement (annual, 2025-09-30) — Net Interest Income: 444107.00
COV.V income_statement (quarterly, 2025-09-30) — Net Interest Income: 112491.00
COV.V cash_flow (annual, 2025-09-30) — Net Issuance Payments Of Debt: -573146.00
COV.V cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -182037.00
COV.V cash_flow (annual, 2025-09-30) — Net Long Term Debt Issuance: -573146.00
COV.V cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -182037.00
COV.V income_statement (annual, 2025-09-30) — Net Non Operating Interest Income Expense: 444107.00
COV.V income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 112491.00
COV.V balance_sheet (annual, 2025-09-30) — Net PPE: 3242063.00
COV.V balance_sheet (quarterly, 2025-09-30) — Net PPE: 3242063.00
COV.V cash_flow (annual, 2025-09-30) — Net PPE Purchase And Sale: -644178.00
COV.V cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -114000.00
COV.V balance_sheet (annual, 2025-09-30) — Net Tangible Assets: 29376235.00
COV.V balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 29376235.00
COV.V income_statement (annual, 2025-09-30) — Normalized EBITDA: 2718615.00
COV.V income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 493990.00
COV.V income_statement (annual, 2025-09-30) — Normalized Income: 2058089.00
COV.V income_statement (quarterly, 2025-09-30) — Normalized Income: 358337.00
COV.V cash_flow (annual, 2025-09-30) — Operating Cash Flow: 2289206.00
COV.V cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -667211.00
COV.V cash_flow (annual, 2025-09-30) — Operating Gains Losses: 150835.00
COV.V cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 1145.00
COV.V income_statement (annual, 2025-09-30) — Operating Income: 1763672.00
COV.V income_statement (quarterly, 2025-09-30) — Operating Income: 245846.00
COV.V income_statement (annual, 2025-09-30) — Operating Revenue: 32816347.00
COV.V income_statement (quarterly, 2025-09-30) — Operating Revenue: 8691972.00
COV.V balance_sheet (annual, 2025-09-30) — Ordinary Shares Number: 27418077.00
COV.V balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 27418077.00
COV.V income_statement (annual, 2025-09-30) — Other Gand A: 7668896.00
COV.V income_statement (quarterly, 2025-09-30) — Other Gand A: 2469783.00
COV.V income_statement (annual, 2025-09-30) — Other Income Expense: -149690.00
COV.V income_statement (quarterly, 2025-09-30) — Other Income Expense: 0.00
COV.V balance_sheet (annual, 2025-09-30) — Other Intangible Assets: 1350674.00
COV.V balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 1350674.00
COV.V cash_flow (annual, 2025-09-30) — Other Non Cash Items: 62555.00
COV.V cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 33501.00
COV.V income_statement (annual, 2025-09-30) — Other Non Operating Income Expenses: -149690.00
COV.V income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 0.00
COV.V income_statement (annual, 2025-09-30) — Other Operating Expenses: 1966937.00
COV.V income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 696357.00
COV.V balance_sheet (annual, 2025-09-30) — Other Properties: 3326520.00
COV.V balance_sheet (quarterly, 2025-09-30) — Other Properties: 3326520.00
COV.V balance_sheet (annual, 2025-09-30) — Other Receivables: 87102.00
COV.V balance_sheet (quarterly, 2025-09-30) — Other Receivables: 87102.00
COV.V balance_sheet (annual, 2025-09-30) — Payables And Accrued Expenses: 3142938.00
COV.V balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 3142938.00
COV.V balance_sheet (annual, 2025-09-30) — Prepaid Assets: 835456.00
COV.V balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 835456.00
COV.V income_statement (annual, 2025-09-30) — Pretax Income: 2058089.00
COV.V income_statement (quarterly, 2025-09-30) — Pretax Income: 358337.00
COV.V cash_flow (annual, 2025-09-30) — Proceeds From Stock Option Exercised: 43800.00
COV.V cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
COV.V balance_sheet (annual, 2025-09-30) — Properties: 0.00
COV.V balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
COV.V cash_flow (annual, 2025-09-30) — Purchase Of Intangibles: -202846.00
COV.V cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: -66214.00